News

Fierce Pharma2d
Novo offers Wegovy discount for new patients, launches new ad campaign as time runs out for compounders
It's plainly apparent that Novo Nordisk has had May 22 circled its calendar since February, when the FDA began the countdown ...
BioPharma Dive2d
Novo pressures GLP-1 compounders as FDA ban takes hold
The Danish drugmaker unveiled a series of initiatives to increase access to Wegovy and clamp down on use of the knock-off ...
Yahoo Finance2d
New Novo Nordisk initiatives support patient access to authentic, FDA-approved Wegovy® as federal ban on mass compounding of "semaglutide" takes effect
PLAINSBORO, N.J., May 22, 2025 /PRNewswire/ -- Today, as the US Food and Drug Administration (FDA) grace period for mass compounding of "semaglutide" expires, Novo Nordisk announced a series of ...
Novo Nordisk joins finance’s great one-hit wonders
In the near term, commercial efforts might raise the chances that new patients are prescribed Novo Nordisk’s drug, assuming ...
Why Novo Nordisk Stock Popped on Tuesday
Novo Nordisk ( NVO 1.82%) stock jumped 3% through 10:55 a.m. Tuesday on some potentially positive news in the GLP-1 weight ...
Investing2d
Novo Nordisk targets counterfeit semaglutide with legal action
Starting today, the mass production or sale of non-approved "semaglutide" drugs is considered illegal under US compounding laws. Novo Nordisk is responding with a special offer for Wegovy ...
Novo Nordisk: Nothing Has Changed, Except That It's Cheaper Now
Novo Nordisk's competitive position is strengthening, driven by strong sales growth in Wegovy, Ozempic, and rare diseases.
LifeMD Collaborates with Novo Nordisk to Launch $299 Introductory Bundle for Self-Pay Patients Prescribed Wegovy®
Bundled Offer Includes Wegovy® at $199 and LifeMD’s Virtual Weight Loss Program for a Total First-Month Cost of $299, $599 per Month ThereafterNEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc.